ASCP Launches Online Toolkit for Diagnosis of Breast Cancer

Share Article

Evidence-based toolkit enhances understanding of HER2 pathways, which play a critical role in cancer biology

The American Society for Clinical Pathology, the world’s largest professional membership organization for pathologists and laboratory professionals, today announced the launch of an evidence-based, online Dx Toolkit designed to enhance the understanding of the diagnosis and management of breast cancer.

Pathologists, Lab Professionals, Residents, and multi-disciplinary team members will have access to educational resources designed to improve best practices resulting in better patient care. The Toolkit is supported by a grant from Genentech.

“The Dx Breast Cancer Toolkit is a flagship example of a professional education just-in-time learning tool,” ASCP Chief Executive Officer E. Blair Holladay said. “Such toolkits are vital to provide the information and education necessary to operationalize new standards in medical care to maximize patient health.”

The Toolkit permits pathologists and medical laboratory professionals to access resources at the point of need. Every resource is organized to seamlessly integrate with the laboratory work flow. The Dx Breast Cancer Toolkit is designed around actionable topics of tumor sampling, sample processing and transportation, testing and image analysis, scoring and interpretation, and reporting and clinician communication.

Unique to all cancer diagnostic education is that knowledge resources have a short shelf life. This site is refreshed on a regular basis with evidence-based research identified by ASCP subject matter experts. The Dx Toolkit leverages resources that are drawn from ASCP’s expansive library of peer-reviewed multimedia courses, academic journals, enduring materials, referential content, and Case of the Month series, which offers peer comparisons.

The toolkit is also designed to enhance understanding of human epidermal growth factor receptor (HER2) pathways, which play a critical role in cancer biology. All resources are evidence-based, actionable and edited for just-in-time learning. For more information, visit

About Genentech
Founded 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit

About ASCP
Founded in 1922 in Chicago, ASCP is a medical professional society with more than 100,000 member board-certified anatomic and clinical pathologists, pathology residents and fellows, laboratory professionals, and students. ASCP provides excellence in education, certification, and advocacy on behalf of patients, pathologists, and laboratory professionals. To learn more, visit Follow us on Twitter at and connect with us on Facebook at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Susan Montgomery
American Society for Clinical Pathology
+1 312-541-4754
Email >
Visit website